Altice USA, Inc. (NYSE:ATUS – Free Report) – Stock analysts at Zacks Research decreased their FY2024 earnings per share (EPS) estimates for Altice USA in a note issued to investors on Tuesday, May 28th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.12 for the year, down […]
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given an average rating of “Buy” by the four ratings firms that are currently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokerages that have issued a report on […]
Condor Capital Management lowered its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 1.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,023 shares of the pharmaceutical company’s stock after selling 75 shares during the period. Condor Capital Management’s holdings in Vertex Pharmaceuticals […]
Isthmus Partners LLC reduced its stake in Summit Hotel Properties, Inc. (NYSE:INN – Free Report) by 49.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,153 shares of the real estate investment trust’s stock after selling 60,954 shares during the […]
Charles Schwab Investment Management Inc. increased its position in shares of The E.W. Scripps Company (NASDAQ:SSP – Free Report) by 21.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,203,306 shares of the company’s stock after acquiring an additional 210,673 shares during the […]